---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-26-000011"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:38:27.493772+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# MariMed restructures $14.2M Series B obligation with $8M notes and 26.9M preferred shares

## Summary
- Old Series B preferred (4,908,333 shares) cancelled, avoiding ~$14.2M cash payout upon mandatory conversion on Feb 28, 2026.
- Issued $2M note due March 2028 at 8% and $6M note due March 2031 at 10% (reduces to 8% if $2M note repaid within 6 months).
- Issued 26.9M shares of new Series B Convertible Preferred Stock with $0.25/sh liquidation preference ($6.725M aggregate).
- New preferred ranks senior to common on dividends/liquidation; conversion options with VWAP-based mechanics.
- Restructuring extinguished all prior obligations to Navy Capital Green; no stockholder approval was required.

## SEC filing metadata
- accession: 0001522767-26-000011
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/0001522767-26-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/mrmd-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-26-000011
- JSON: https://secwatch.observer/filing/0001522767-26-000011.json
- Plain text: https://secwatch.observer/filing/0001522767-26-000011.txt

## Source-grounded claims
- claim_id: 59b6cd214deda0d3072f6d2687b3fabbc6baad18
  claim: MARIMED INC. incurred senior notes of principal amount of $6,000,000 with Navy Capital Green International, Ltd. and its affiliates at 10.0% per annum maturing March 1, 2031.
  evidence_excerpt: the Company issued to Navy (i) two new promissory notes in the aggregate principal amount of $8,000,000, one in the principal amount of $2,000,000, due March 1, 2028, accruing interest at a rate of 8.0% per annum ("Note #1") and the other in the principal amount of $6,000,000, due March 1, 2031, accruing interest at a rate of 10.0% per annum (subject to reduction to 8% if Note #1 is paid in full within six (6) months of February 24, 2026) ("Note #2" collectively with Note #1, the "New Notes")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/0001522767-26-000011-index.htm
- claim_id: 5e681f32b470f9c8d626ea0eebe3a6c061c4d541
  claim: MARIMED INC. incurred senior notes of aggregate principal amount of $8,000,000 with Navy Capital Green International, Ltd. and its affiliates at 8.0% per annum maturing March 1, 2028.
  evidence_excerpt: the Company issued to Navy (i) two new promissory notes in the aggregate principal amount of $8,000,000, one in the principal amount of $2,000,000, due March 1, 2028, accruing interest at a rate of 8.0% per annum ("Note #1")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/0001522767-26-000011-index.htm
- claim_id: f45b3484672654d8022db94293118ce17128076c
  claim: MARIMED INC.: Filed a Second Amended and Restated Certificate of Designation to designate the rights and preferences of the New Series B Preferred Stock (effective 2026-02-26).
  evidence_excerpt: On February 26, 2026, in connection with the Loan Restructuring Transaction, the Company filed a Second Amended and Restated Certificate of Designation to designate the rights and preferences of the New Series B Preferred Stock with the Secretary of State of Delaware.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/0001522767-26-000011-index.htm
- claim_id: 28e7f019d1b1cc103c28cbccd5918446645b15c4
  claim: MARIMED INC. entered into Restructuring and Exchange Agreement with Navy Capital Green International, Ltd. valued at $8,000,000 (effective 2026-02-24).
  evidence_excerpt: On February 24, 2026, the Company and Navy entered into a Restructuring and Exchange Agreement (the “Restructuring and Exchange Agreement”) to address and restructure the Series B Obligation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000011/0001522767-26-000011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.